Research ArticleInflammation, Immunopharmacology, and Asthma
Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes
Afshin Ebrahimpour, Samana Shrestha, Mark D. Bonnen, N. Tony Eissa, Ganesh Raghu and Yohannes T. Ghebre
Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 169-178; DOI: https://doi.org/10.1124/jpet.118.252650
Afshin Ebrahimpour
Departments of Radiation Oncology (A.E., S.S., M.D.B., Y.T.G.) and Medicine, Section on Pulmonary and Critical Care Medicine (N.T.E., Y.T.G.), Baylor College of Medicine, Houston, Texas; and Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, Washington (G.R.)
Samana Shrestha
Departments of Radiation Oncology (A.E., S.S., M.D.B., Y.T.G.) and Medicine, Section on Pulmonary and Critical Care Medicine (N.T.E., Y.T.G.), Baylor College of Medicine, Houston, Texas; and Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, Washington (G.R.)
Mark D. Bonnen
Departments of Radiation Oncology (A.E., S.S., M.D.B., Y.T.G.) and Medicine, Section on Pulmonary and Critical Care Medicine (N.T.E., Y.T.G.), Baylor College of Medicine, Houston, Texas; and Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, Washington (G.R.)
N. Tony Eissa
Departments of Radiation Oncology (A.E., S.S., M.D.B., Y.T.G.) and Medicine, Section on Pulmonary and Critical Care Medicine (N.T.E., Y.T.G.), Baylor College of Medicine, Houston, Texas; and Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, Washington (G.R.)
Ganesh Raghu
Departments of Radiation Oncology (A.E., S.S., M.D.B., Y.T.G.) and Medicine, Section on Pulmonary and Critical Care Medicine (N.T.E., Y.T.G.), Baylor College of Medicine, Houston, Texas; and Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, Washington (G.R.)
Yohannes T. Ghebre
Departments of Radiation Oncology (A.E., S.S., M.D.B., Y.T.G.) and Medicine, Section on Pulmonary and Critical Care Medicine (N.T.E., Y.T.G.), Baylor College of Medicine, Houston, Texas; and Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, Washington (G.R.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleInflammation, Immunopharmacology, and Asthma
Nicotine Enhances Inflammatory and Fibrotic Processes
Afshin Ebrahimpour, Samana Shrestha, Mark D. Bonnen, N. Tony Eissa, Ganesh Raghu and Yohannes T. Ghebre
Journal of Pharmacology and Experimental Therapeutics February 1, 2019, 368 (2) 169-178; DOI: https://doi.org/10.1124/jpet.118.252650
Research ArticleInflammation, Immunopharmacology, and Asthma
Nicotine Enhances Inflammatory and Fibrotic Processes
Afshin Ebrahimpour, Samana Shrestha, Mark D. Bonnen, N. Tony Eissa, Ganesh Raghu and Yohannes T. Ghebre
Journal of Pharmacology and Experimental Therapeutics February 1, 2019, 368 (2) 169-178; DOI: https://doi.org/10.1124/jpet.118.252650
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement